These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 8350962

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. 9-Hydroxybenfluron: cytostatic effects and inhibition of macromolecular biosynthesis in Ehrlich ascites and P388 murine leukemia cells.
    Miko M, Krepelka J, Melka M.
    Anticancer Drugs; 1991 Jun; 2(3):289-95. PubMed ID: 1802025
    [Abstract] [Full Text] [Related]

  • 3. Cytotoxicity and mode of action of the potential cytostatic drug oracin.
    Miko M, Poturnajova M, Soucek R.
    Neoplasma; 2002 Jun; 49(3):167-71. PubMed ID: 12098002
    [Abstract] [Full Text] [Related]

  • 4. Cytoxicity of 1-alkylperhydroazepine N-oxides and quantitative structure-activity relationships.
    Miko M, Devinsky F.
    Int J Biochem Cell Biol; 1998 Nov; 30(11):1253-64. PubMed ID: 9839450
    [Abstract] [Full Text] [Related]

  • 5. In vitro cytotoxic activity of 1-alkylpiperidine N-oxides and quantitative structure-activity relationships.
    Miko M, Devinsky F.
    Anticancer Drugs; 1993 Jun; 4(3):355-63. PubMed ID: 8358065
    [Abstract] [Full Text] [Related]

  • 6. Primary screening and inhibition of macromolecular biosynthesis by benfluron metabolites in vitro.
    Miko M, Krepelka J, Mĕlka M, Vajdová D.
    Neoplasma; 1989 Jun; 36(1):91-101. PubMed ID: 2704427
    [Abstract] [Full Text] [Related]

  • 7. Relationships between the chemical structure and cytotoxicity of 4-alkylmorpholine N-oxides.
    Miko M, Devínsky F.
    Drug Metabol Drug Interact; 1991 Jun; 9(3-4):333-51. PubMed ID: 1824086
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of biosynthetic processes in P388 and Ehrlich ascites cells by cloturin.
    Miko M, Krepelka J, Melka M.
    Drugs Exp Clin Res; 1988 Jun; 14(9):575-80. PubMed ID: 3229320
    [Abstract] [Full Text] [Related]

  • 9. Primary screening and inhibition of macromolecular biosynthesis in Ehrlich ascites cells by benzo(C)fluorene derivatives.
    Miko M, Krepelka J, Melka M.
    Drug Metabol Drug Interact; 1991 Jun; 9(1):1-22. PubMed ID: 1893750
    [Abstract] [Full Text] [Related]

  • 10. Effect of 1-alkylpyrrolidine N-oxides on energy metabolism of cancer cells.
    Miko M, Devínsky F.
    Neoplasma; 1993 Jun; 40(4):205-11. PubMed ID: 8272146
    [Abstract] [Full Text] [Related]

  • 11. New potential cytotoxic and antitumor substances I. In vitro effect of bikaverin and its derivatives on cells of certain tumors.
    Fuska J, Proksa B, Fusková A.
    Neoplasma; 1975 Jun; 22(3):335-8. PubMed ID: 1172201
    [Abstract] [Full Text] [Related]

  • 12. In vitro effect of alpha, beta-unsaturated sulphones of the 5-nitrofuran series on the incorporation of C-labelled precursors into Ehrlich's ascites carcinoma cells.
    Fuska J, Fusková A, Jurásek A.
    Acta Biol Med Ger; 1978 Jun; 37(2):199-204. PubMed ID: 568367
    [Abstract] [Full Text] [Related]

  • 13. In vitro effect of duclauxin and derivatives of coumarin on nucleic acid and protein synthesis in Ehrlich's Ascites Carcinoma cells (EAC).
    Fusková A, Proksa B, Fuska J.
    Pharmazie; 1977 May; 32(5):291-3. PubMed ID: 896926
    [Abstract] [Full Text] [Related]

  • 14. New potential cytotoxic and antitumor substances. II. Effect of hydroxyanthraquinones and their glucosides on Ehrlich ascites carcinoma cells in vitro.
    Fuska J, Fusková A, Vanĕk Z.
    Neoplasma; 1976 May; 23(2):227-30. PubMed ID: 934391
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of DNA and RNA synthesis by daunorubicin in sensitive and resistant Ehrlich ascites tumor cells in vitro.
    Dano K, Frederiksen S, Hellung-Larsen P.
    Cancer Res; 1972 Jun; 32(6):1307-14. PubMed ID: 5063994
    [No Abstract] [Full Text] [Related]

  • 16. Effect of N1-(2'-tetrahydrofuryl)-5-fluorouracil and 5-fluorouracil on nucleic acid and protein biosyntheses in Ehrlich ascites cells.
    Fujimoto S, Akao T, Itoh B, Koshizuka I, Koyano K.
    Cancer Res; 1976 Jan; 36(1):33-6. PubMed ID: 1248008
    [Abstract] [Full Text] [Related]

  • 17. Studies on the mechanism of action of anthramycin methyl ether, a new antitumor antibiotic.
    Bates HM, Kuenzig W, Watson WB.
    Cancer Res; 1969 Dec; 29(12):2195-205. PubMed ID: 5387260
    [No Abstract] [Full Text] [Related]

  • 18. Metabolic activity of the Ehrlich ascites carcinoma cells and the significance of ascites serum addition.
    Miko M, Drobnica L.
    Neoplasma; 1969 Dec; 16(2):161-9. PubMed ID: 5822918
    [No Abstract] [Full Text] [Related]

  • 19. Studies of the mode of action of N-isopropyl-alpha-(2-methylhydrazino)-p-toluamide.
    Gale GR, Simpson JG, Smith AB.
    Cancer Res; 1967 Jul; 27(7):1186-91. PubMed ID: 4952509
    [No Abstract] [Full Text] [Related]

  • 20. [Effects of bimolane and probimane on the incorporation of (3H)TdR, (3H)UR and (3H)Leu into Ehrlich ascites carcinoma cells iv vitro].
    Wang MY, Liu TX, Li GD, Zhang TM.
    Zhongguo Yao Li Xue Bao; 1988 Jul; 9(4):367-9. PubMed ID: 3195348
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.